These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30995468)

  • 1. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
    Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
    Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
    Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
    J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner.
    Kalender A; Selvaraj A; Kim SY; Gulati P; Brûlé S; Viollet B; Kemp BE; Bardeesy N; Dennis P; Schlager JJ; Marette A; Kozma SC; Thomas G
    Cell Metab; 2010 May; 11(5):390-401. PubMed ID: 20444419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice.
    Huang X; Wullschleger S; Shpiro N; McGuire VA; Sakamoto K; Woods YL; McBurnie W; Fleming S; Alessi DR
    Biochem J; 2008 Jun; 412(2):211-21. PubMed ID: 18387000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological activators of AMP-activated protein kinase have different effects on Na+ transport processes across human lung epithelial cells.
    Woollhead AM; Sivagnanasundaram J; Kalsi KK; Pucovsky V; Pellatt LJ; Scott JW; Mustard KJ; Hardie DG; Baines DL
    Br J Pharmacol; 2007 Aug; 151(8):1204-15. PubMed ID: 17603555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
    Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
    Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
    Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
    PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IKK promotes cytokine-induced and cancer-associated AMPK activity and attenuates phenformin-induced cell death in LKB1-deficient cells.
    Antonia RJ; Baldwin AS
    Sci Signal; 2018 Jul; 11(538):. PubMed ID: 29991651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
    Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
    Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
    J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
    Shackelford DB; Abt E; Gerken L; Vasquez DS; Seki A; Leblanc M; Wei L; Fishbein MC; Czernin J; Mischel PS; Shaw RJ
    Cancer Cell; 2013 Feb; 23(2):143-58. PubMed ID: 23352126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor.
    Liu JL; Mao Z; Gallick GE; Yung WK
    Neuro Oncol; 2011 Feb; 13(2):184-94. PubMed ID: 21123367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration.
    Zhang L; He H; Balschi JA
    Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H457-66. PubMed ID: 17369473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic perturbators metformin, phenformin and AICAR interfere with the growth and survival of murine PTEN-deficient T cell lymphomas and human T-ALL/T-LL cancer cells.
    Rosilio C; Lounnas N; Nebout M; Imbert V; Hagenbeek T; Spits H; Asnafi V; Pontier-Bres R; Reverso J; Michiels JF; Sahra IB; Bost F; Peyron JF
    Cancer Lett; 2013 Aug; 336(1):114-26. PubMed ID: 23612073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-Dependent AMPK-Dependent and Independent Mechanisms of Berberine and Metformin Inhibition of mTORC1, ERK, DNA Synthesis and Proliferation in Pancreatic Cancer Cells.
    Ming M; Sinnett-Smith J; Wang J; Soares HP; Young SH; Eibl G; Rozengurt E
    PLoS One; 2014; 9(12):e114573. PubMed ID: 25493642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways.
    Huang Y; Zhou S; He C; Deng J; Tao T; Su Q; Darko KO; Peng M; Yang X
    Cancer Commun (Lond); 2018 Jul; 38(1):50. PubMed ID: 30053908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5'AMP-Activated Kinase Inactivation.
    Tosello V; Bongiovanni D; Di Martino L; Franchin C; Zanovello P; Arrigoni G; Piovan E
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
    Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
    Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications.
    Grimaldi C; Chiarini F; Tabellini G; Ricci F; Tazzari PL; Battistelli M; Falcieri E; Bortul R; Melchionda F; Iacobucci I; Pagliaro P; Martinelli G; Pession A; Barata JT; McCubrey JA; Martelli AM
    Leukemia; 2012 Jan; 26(1):91-100. PubMed ID: 21968881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.